Inceptua Group Expands Early Access Program to Latin America

Inceptua Group announces an expansion of an Early Access Program for cefiderocol for eligible patients in Argentina, Chile, Colombia, Guatemala, Mexico, and Panama.

Vector Laboratories Merges With Absolute Biotech, Significantly Expanding Capabilities as a Critical Component Manufacturer for Life Science Customers

Vector Laboratories joins forces with Absolute Biotech, bolstering its role as a key manufacturer for life science customers, enriching its antibody reagents portfolio, and expanding its commercial presence into the UK and EU.

PrecisionLife and Metrodora Institute Launch Clinical Trials to Accelerate the Diagnosis and Treatment of ME/CFS and Long Covid Patients

Metrodora Institute and PrecisionLife announce the start of recruitment on a cohort of up to 1,000 patients into clinical trials to evaluate new diagnosis and treatment options for ME/CFS, Long Covid, and related disorders.

Indica Labs Receives First FDA Clearance for HALO AP Dx Digital Pathology Platform

Indica Labs announced today that it received FDA clearance for HALO AP Dx, an enterprise digital pathology platform, for primary diagnosis.

Elegen Raises $35 Million in Series B to Accelerate Expansion into Clinical Manufacturing

Elegen is leveraging their next-generation DNA synthesis and production technology to expand into clinical DNA scaleup and manufacturing, a move supported by this Series B round with new investors Trianomic Capital, GSK, and Aldevron co-founder John Ballantyne as well as existing investors. This expansion into clinical applications comes just a little over a year after launching their first product, ENFINIA DNA. To date the company has rapidly enhanced its platform to speed the upstream discovery phase of genetic medicine development, and in January announced a collaboration and licensing agreement with GSK. Investors are confident that Elegen's cell-free, turnkey synthetic DNA platform will transform the speed and reliability of clinical GMP DNA manufacturing.

ZeOmega Supports Health Plan Alliance with Payvider Solutions 

Kalderos Names Healthcare Industry Veteran Daryl Todd as Chief Strategy Officer

Kalderos Names Healthcare Industry Veteran Daryl Todd as Chief Strategy Officer

InsightRX Continues Momentum in Precision Dosing with Client Growth, New Scientific Breakthroughs

InsightRX Continues Momentum in Precision Dosing with Client Growth, New Scientific Breakthroughs

Cotiviti Client Conference Brings Together Health Plan Leaders to Strengthen Healthcare Ecosystem through Technology and Expertise

PathAI Announces PLUTO: a State-of-the-Art Foundation Model to Enhance AI-powered Pathology Tools

PLUTO’s embeddings will enable prediction of underlying molecular alterations driving cancer and disease phenotypes–including those previously hidden to AI–as well as the discovery of new biomarkers and therapeutic targets.

Optibrium Partners with FMC Corporation to Transform Agrochemical Discovery

Optibrium’s AI-powered discovery platform Cerella™ chosen by FMC to accelerate its agrochemical discovery pipeline

FDB Expands its Medication Instructions to Include Translations of Hindi & Punjabi, 2 of the Fastest-Growing Languages in the US

https://www.prnewswire.com/news-releases/fdb-expands-its-medication-instructions-to-include-translations-of-hindi--punjabi-2-of-the-fastest-growing-languages-in-the-us-302141989.html?tc=eml_cleartime

Switchboard Health Announces $6.5M Series Seed Funding to Support New Partnerships with Health Plans and Value-Based Care Providers

Switchboard Health, creator of a high-value specialty care network and software platform, has secured $6.5 million in series seed funding.

Torbay Pharma strengthens leadership team to support North American growth strategy

Baylor Genetics Launches RNASeq Test for Whole Genome and Whole Exome Sequencing, Reduces Turnaround Times, Introduces Four New Genetic Analysis Panels

Baylor Genetics, a clinical diagnostic laboratory at the forefront of genetic testing, today announced the availability of a new RNA sequencing test, RNAseq, for Whole Exome and Whole Genome Sequencing (WES/WGS). The company also reduced its standard turnaround time on WES and WGS to three weeks and continues to provide rapid testing with written reports in as few as five days.

Watson-Marlow introduces DriveSure® OEM pump solution at ACHEMA 2024

Watson-Marlow Fluid Technology Solutions (WMFTS) will showcase its recently launched DriveSure® panel mount pumps along with other products for life sciences companies at ACHEMA 2024 in Germany (June 10-14).

Cresset® appoints new Chairman

Guy’s and St Thomas’ NHS Foundation Trust Harnesses PhenoTips’ Genomic Health Record to Finalise 5 Year Strategy: Together We Care

Built on the strong visions and values of the Trust, Guy’s and St Thomas’ “Together We Care” strategy centers on three primary priorities, Patients, People, and Partnerships, aiming to bolster patient autonomy, invest in staff, and harness technologies in collaboration with commercial partners. Guy’s and St Thomas’ implementation of PhenoTips’ Genomic Health Record on the final year of their 2018-2023 strategy completes the ambitious 5-year plan by empowering patients to take an active role in the collection of their data, streamlining staff and provider workflows, and establishing a framework for deep integration between the partner technologies supporting the Trust.

Scientists have discovered a method to treat neurological diseases without heart-related side effects

The biotech startup Lactocore Group has reported unusual properties of a proprietary peptide, LCGA-17m16, aimed at treating neurological disorders without harming the heart that signal a potential paradigm shift in treating neurological disorders.

Cresset Targets Global Growth with New India HQ

Drug discovery specialist Cresset has announced a major milestone in its international growth with the launch of a new Indian HQ in Bangalore